[Goanet] (PDF) "Konkani and 'Goan Identity’ in Post-Colonial Goa", Journal of the Japanese Association for South Asian Studies 14: 121-144, 2002 | Kyoko Matsukawa - Academia.edu

[Frederick Dsouza]

(PDF) "Konkani and 'Goan Identity’ in Post-Colonial Goa", Journal of the
Japanese Association for South Asian Studies 14: 121-144, 2002 | Kyoko
Matsukawa - Academia.edu


https://www.academia.edu/33253772/_Konkani_and_Goan_Identity_in_Post_Colonial_Goa_Journal_of_the_Japanese_Association_for_South_Asian_Studies_14_121_144_2002

[Goanet] GOA IS A LAND WORTH FIGHTING FOR

[Aires Rodrigues]

It is 12 long years since that gruesome attack on me at Panaji’s Ashok
Restaurant on that Friday 13th October 2008. It was a miraculous escape
after that deadly armed assault.  I owe it all to the doctors for their
timely medical attention that night.

Over the years I have always remain unperturbed. I would rather die with a
hope, rather than have hope die inside me. I hope my fellow Goans,
especially the younger generation, will battle against injustice and
corruption. Each of us has to go someday, but our Goa must exist forever.

When we do depart, it must be with a proud sense of accomplishment of at
least having attempted to do everything possible for Goa. I remain heavily
indebted to all my teachers in school and college who imparted me the
knowledge, guidance and confidence that has helped me immensely in all the
crusades. We need to witness that glorious day when Goa will be truly
liberated from injustice, corruption and nepotism, all sadly a way of life
today.

In the words of Corazon Aquino, widow of assassinated President of the
Philippines, who went on to be President herself:  *“I would rather die a
meaningful death than live a meaningless life”.* And as the sufi mystic
Kabir said *“Jako rakhe Sai, maar sake na koi”* (None can harm him who is
looked after by higher Powers).

Aires Rodrigues

Advocate High Court

C/G-2, Shopping Complex

Ribandar Retreat,

Ribandar – Goa – 403006

Mobile No: 9822684372

Office Tel  No: (0832) 2444012

Email: airesrodrigu...@gmail.com

 Or

   airesrodrig...@yahoo.com

You can also reach me on

Facebook.com/ AiresRodrigues

Twitter@rodrigues_aires


www.airesrodrigues.com

[Goanet] Home - Canossa Hospital

[Gabe Menezes]

Reading about St Jodeph's Belgaum and the Hong Kong connection, I
remembered this Hodpital, our neigh ours on Old Peak Road, H.K.

https://www.canossahospital.org.hk/en/

[Goanet] Schedule for Wednesday 14th October 2020

[CCR TV]

CCR TV GOA
Channel of God's love✝

You can also watch CCR TV live on your smart phone via the CCR TV App
Available on Google PlayStore for Android Platform.
Click the link below.
https://play.google.com/store/apps/details?id=ccr.tv4
Email ID:  ccrgoame...@gmail.com

Schedule for Wednesday 14th October 2020

12:00 AM
Rosary - Glorious Mysteries

12:24 AM
Fatherhood - Talk by Kenneth D'Sa

12:56 AM
Music - Bavarth - Fr Eusico Pereira

1:00 AM
Mass in Konkani for Tuesday

1:45 AM
Praise and Worship - Debbie DSouza

2:00 AM
Saibinnichi Ruzai -  Orkache Mister

2:24 AM
Our Father - Give us today our daily bread - Fr Ronnie D'Souza sj

2:40 AM
Adoration - Fr Oscar Nazareth op

3:00 AM
Media Track - Episode 56

3:30 AM
Amchi Bhas Amche Borovpi  - Fr Tomas Lobo interviewed by Daniel F. de Souza

4:00 AM
Repentance - Talk by Jorim Mendonca

4:52 AM
I am the Good Shepherd -Talk by Kirona Noronha

5:17 AM
Our Journey Through Covid 19 - A Testimony

5:46 AM
Childline

6:10 AM
Amchi Bhas Amche Borovpi - Pio Esteves interviewed by Daniel de Souza

6:51 AM
My Music Videos - Golden Sunset - Kevin Mendes

6:57 AM
Sokalchem Magnnem  -  Rogtsakxi

7:00 AM
Mass in Cortalim Church followed by Jivitacho Prokas

7:45 AM
Morning Prayer  -  Martyrs

7:50 AM
Bhajans 3

8:18 AM
Music - Fatorda Youth followed by Povitr Atmeak Dispottem Magnnem

8:50 AM
Inner Healing -  Talk by Sr Elsis Mathew MSMI

9:18 AM
Catechism for First Holy Communion - 9 -DCC

9:37 AM
Prayer over Children - St Jospeh Vaz

9:40 AM
Life is Worth Living - Talk by Sr Sirisha Kota

9:50 AM
Iodn Naka Mhaka Doya Zai - Talk by Mathew Fernandes

10:10 AM
Devache Dhonniponn amchea Jivitant - Talk by Orlando D'Souza

10:35 AM
Catechism for Confirmation - 9 - DCC

11:00 AM
Hymn - Saibinichi Bhett Tujea Ghorant - Fr Ronaldo Fernandes

11:08 AM
Our Father - Sadri

11:15 AM
National Anthem - Goa University Choir

11:17 AM
Intercessions (English)

11:30 AM
Mass in English  Cortalim Church followed by Daily Flash

12:15 PM
On the Third Day - Eps 3 - Wealth out of Waste

12:40 PM
Mon Bodlun Bapachea - Talk by Fr Victor

1:10 PM
Literally Goa  - Heta Pandit interviewed by Frederick Noronha

1:38 PM
Hymn - Mhojea Deva Tum Sorv- Fr Seville Antao OFM(Cap)

1:41 PM
Bhagevont Francis de Assis - Dusro Krist - Fr Jose D'Souza OFM Cap

2:03 PM
Music - Coracao Santo 2 - Victor Da Costa

2:05 PM
Media Track - Episode 56

2:35 PM
Commitment - Talk by Kenneth D'Sa

3:02 PM
Bhagevont Zuze Vazachem Novena Magnnem

3:05 PM
Hymns - St Lawrence HS - Agassaim

3:11 PM
Konkani Bhas - Bhag 8 - Fr Pratap Naik sj

3:30 PM
Deivik Kaklutichi Magnneam

3:47 PM
Ximpientlim Motiam - Bhag  111 Bhogsonnem  - Fr Pratap Naik sj

3:57 PM
Magnificat (English)

4:00 PM
Rosary - Glorious Mysteries

4:24 PM
Reflection on the Gospel - Dominicans

4:30 PM
Senior Citizens Exercises - 7

4:53 PM
My Music Videos - Hanv Missionar

4:58 PM
Praise and Worship -  Cajetan D'Costa

5:17 PM
The Importance of Introspection - Talk by Sr Saral

5:30 PM
Live Novena Mass 2 Colva

6:30 PM
Novena 6  Nagoa

7:16 PM
Intercessions  -  Konkani

7:28 PM
Angelus - English

7:30 PM
Saibinnichi Ruzai -  Orkache Mister

7:55 PM
Prayer for Healing from Cancer

8:00 PM
Wisdom Reflections -5 - Rachol Professors

8:30 PM
Are we Pharisees? - Dr Brenda Nazareth Menezes

9:00 PM
Adoration 8 - St Anthony Church, Siolim

9:30 PM
Ratchem Magnem

9:45 PM
Our Journey Through Covid 19 - A Testimony

10:14 PM
Couples Prayer (Konkani)

10:19 PM
Career Guidance Goa College of  Home Science

10:55 PM
The Earth - Our Home - Wild Otters in Goa

11:23 PM
The Holy Eucharist - Talk By Msgr. Alex Rebello

Donations may be made to:
Beneficiary name : CCR GOA MEDIA.
Name of Bank : ICICI Bank
Branch Name: Candolim Branch
RTGS/NEFT Code : ICIC0002624
Savings Bank Account No : 262401000183

[Goanet] Harappa to Vijaynagar to Kadamba to Bijapur - Colonies galore.

[eric pinto]

 

     

Harappan India - clearly African, from recovered statues.  They proceeded to 
settle Australia 20K years ago. Dravid Vijaynagar India. Their tongue akin to 
native Moroccan spoken by the Berber majority of the country. They had moved 
north from the Lake Victoria valley.
Kadamba Gove, these Afghan Aryas located Goa with the grace of god, and a 
divine arrow. Bijapur Sultanate, gentlemen out of Georgia, Uzbeg lands,  
Islamic Afghan territory

 __,_._,___  

[Goanet-News] The Stray Dogs of Goa (Norma Alvares)

[Frederick Noronha]

https://www.facebook.com/watch/live/?v=1059481751138308=watch_permalink
-- 
FN* फ्रेड्रिक नोरोन्या * فريدريك نورونيا‎ +91-9822122436

[Goanet-News] Midwifery in Goa...by Viviato J Pinto

[Frederick Noronha]

https://upload.wikimedia.org/wikipedia/commons/7/7e/Midwifery_in_Goa_%28IA_101734681.nlm.nih.gov%29.pdf

-- 
FN* फ्रेड्रिक नोरोन्या * فريدريك نورونيا‎ +91-9822122436

[Goanet] The Stray Dogs of Goa (Norma Alvares)

[Frederick Noronha]

https://www.facebook.com/watch/live/?v=1059481751138308=watch_permalink
-- 
FN* फ्रेड्रिक नोरोन्या * فريدريك نورونيا‎ +91-9822122436

[Goanet] St. Joseph's Belgaum

[Mervyn Maciel]

Thanks for  posting that link, Fred.
I remember St. Joseph's so well as I used
to serve Mass regularly at the Convent chapel.
We, young boys also used to always try and
get a sneak view of the girls and I think they
did the same whenever we were playing on the open
maidan!
Some memories - remember some of the nuns too -
my favourite was Mother Rose!


Mervyn Maciel

[Goanet] {Dilip's essays} Significance of double-blind drug trials

[Dilip D'Souza]

October 13 2020

And here's the sequel, in which I delve a little into the mathematics of
drug trials:
https://www.livemint.com/opinion/columns/opinion-significance-of-double-blind-drug-trials-11602211204718.html

I look forward to any thoughts/questions/remarks/criticism/corrections from
you.

cheers,
dilip



Significance of double-blind drug trials


Two weeks ago, I offered “a broad and not necessarily definitive outline”
of the clinical trials of new vaccines against covid-19. Apart from the
hope that we will produce a weapon to fight the virus, what really
interests me about these trials is that they are essentially mathematical
exercises. Since any vaccine that results from these trials will be
important to us all, I will explore some of that mathematics here.

Much of what happens in such exercises involves searching for results we
need to take note of, that carry some weight. Start at the top. We want to
find a medicine that is effective against covid, so how do we determine
that one we are testing is (or is not) effective?

Let’s say we have 100 people who have volunteered for the trials. We’ve
divided them into two groups of 50 each. One will be administered the
experimental drug, the other a placebo — i.e. something that looks
identical, but has no medicinal value at all. There are rules for
administering a placebo correctly, and I’ll come to those. For now, let’s
assume they have been followed.

The trial runs its course. The placebo group reports that one person has
recovered, whereas the group that got the actual drug reports that five
have recovered. What, if anything, can we conclude? Is this just chance? Is
there a real difference between the groups? Is this enough to conclude
anything about the efficacy of the drug?

When quantitative methods like trials produce a result, statisticians
search for something called “statistical significance” in that result.
Meaning, evidence that it cannot be attributed to chance. The usual measure
to decide this is called the “p-value”. This is the probability of
observing the difference you found between the two groups if they were
otherwise identical in every respect, including in what’s been administered
to them.

There’s a certain calculation involved here (usually called the “A/B test
calculation”) whose intricacies I won’t get into. But there are A/B test
calculators online, and I fed the numbers above, from our hypothetical two
groups above, to one of them. It reported a p-value of 0.0938, or 9.38%.

What this means is that we can expect to randomly — i.e. by chance — see a
difference of 5% or more between these two groups about 9.38% of the time.
That’s confusing; so more simply, pure chance would account for the
variance we’ve detected about 94 times of every 1000 times we run this
test. The other 906 times, we can attribute this difference to the effect
of the medicine. With this knowledge, what we need to decide is, is this
9.38% level acceptable? Is it low enough for us to take the measured
difference between the two groups seriously? As statistically significant?

To put that in perspective, let’s say the second group, the one taking the
drug, saw not five, but just two recoveries. Still different from the one
recovery from among the placebo recipients, but how different is it,
really? The same A/B test calculator now gives us a p-value of 0.5597, or
55.97%. So of every 1000 times we run this test, random chance will produce
a reasonable difference between these two groups 560 times. The sensible
conclusion you probably came to, as I did: this difference between these
two groups is likely just pure chance, and this particular drug under test
is not really different from a placebo.

The five recoveries? Now that’s more like a real difference. But even so, a
generally accepted threshold for statistical significance is a p-value less
than 0.05, or 5%. Put another way, we want to be 95% “confident” that the
variance we’ve detected is real, and not due to chance. In this case, we’re
only 90.6% confident (the 906 out of 1000 above). So most statisticians
would not read very much into even the five recoveries. In fact, even the
calculator tells me this difference is “not significant”.

One reason for that, and a factor in any such calculation, is the sample
size — the number of people we are running the test on. Intuitively, you
will agree that the greater that number, the more confidence we can have
that our results are real. Conversely, the smaller our sample size, the
less confident we’ll feel. To make this clear, let’s say we run the test on
two groups, each comprising 500 volunteers instead of 50. We’ll keep the
recovery rates the same: in the placebo group, 10 of the 500 recover; in
the other, 50 do. Feed those figures into the A/B calculator and we get a
p-value less than 0.001: not even 1 test in a thousand will produce this
difference purely by chance.

That is, with this increased sample size, even with the same rate of
recovery, we 

[Goanet] {Dilip's essays} Vaccine Phasebook: The Essence of Trials

[Dilip D'Souza]

Oct 13 2020

These days, there are almost daily reports about how a vaccine for the
coronavirus is around the corner. Possibly still a rather large corner, but
of course everyone wants to find a vaccine, some kind of protection against
this spectre that's haunted us for most of this year.

Labs in various parts of the world are now testing possible vaccines, and I
wanted to write a column exploring that process, specifically its
fundamentally mathematical nature. I couldn't fit everything into one
column, though.

So here's the first column I wrote, explaining the general idea of drug
trials (Mint September 25):
https://www.livemint.com/opinion/columns/vaccine-phasebook-the-essence-of-trials-11600965107078.html

The next bit of mail from me will have the sequel.

yours,
dilip

---

Vaccine phasebook: the essence of trials


It’s one of those pandemic sidelights. We’ve learned plenty of resonant
phrases and concepts that we might not otherwise have done. Like:
exponential growth, herd immunity (or even, as a certain President recently
had it, herd mentality), peaking … and Phase 1, or even 2 and 3.

Those last three refer to clinical trials of vaccines to fight the virus.
That is, a potential vaccine has to go through three different kinds of
trials, each more elaborate and wide-ranging than the previous. Only after
it has passed those trials can the vaccine be put on the market for
widespread use. With this particular virus, there are efforts around the
globe to find a vaccine, and some are now starting on Phase 3 trials.

This may mean a vaccine will be available soon. Or not. There’s doubt
because it must actually pass the Phase 3 trials, and we don’t know if it
will. But what we have no doubt about is that we don’t yet have a vaccine.
Oh, there are those who may tell you different. They may try to sell you a
“cure” for the virus that will give you “100% recovery” from it. Until it
has gone through those trials, treat such “cures” as the snake-oil they are.

But leave aside snake-oil. What do those trials entail, anyway?

Let’s say you lead a lab that has been working feverishly for weeks with
the corona molecule. You’ve made progress. You’ve identified its
vulnerabilities and have put together a cocktail of chemicals to mount an
attack on them. At least on your Petri dishes and under your microscopes,
the cocktail seems able to neutralize or even destroy the virus. It’s time,
you believe, to try it on humans.

Thus Phase 1. This is a trial in which you ask for a few healthy volunteers
— typically a few dozen — and administer the cocktail to them, the first
people to get it. Why healthy? Think about it: the first priority with a
new medicine must be to ensure it doesn’t cause some entirely different
complications in otherwise healthy people. This is particularly important
when a virus has caused so many infections that there is already an undue
strain on health care systems.

Nevertheless, the kinds of questions you want answered in Phase 1 are: does
the vaccine have any side-effects? If so, does the size of the dose make a
difference to the side-effects? Is it safe? And of course, does it appear
to be working?

Also, with any new medicine, you want to find its most appropriate dosage,
with the fewest side-effects. So the first few volunteers are given a very
low dose and observed closely. If side-effects are only minor, the next set
of volunteers get a higher dose. This cycle repeats until we find a dose
strength that seems to work, while only causing an acceptable level of
side-effects. This is called the “maximum tolerated dose” of the potential
vaccine.

When Phase 1 tests suggest that the new medicine is safe, it’s time for
Phase 2. This time, you call for a larger number of volunteers, perhaps a
few hundred. While they are not all infected with the virus, many are. They
are treated with doses of the medicine up to the maximum tolerated dose, as
identified in Phase 1.

Again, there are questions that need answers. How effective is the medicine
in preventing the virus from infecting healthy people, and in treating
people who are already infected — that is, does the medicine work as
preventive vaccine and curative drug? Is there an “optimum dosage” — short
of the maximum tolerated dose — that we can identify? Does the medicine
affect the volunteers’ immune systems, and if so how? How do factors like
age and gender affect its effectiveness?

Typically in Phase 2, there will also be a group of patients simultaneously
being given a placebo — meaning something that looks identical to the
treatment under trial, but that has no medicinal value and does nothing by
way of treatment. The point here is to establish a standard, a reference,
against which the performance of the new drug can be measured. Absent such
a “control” reference, how can you conclude that the medicine is working?

And if you do come to that conclusion, you will probably embark on Phase 3
trials. By this time, you have a good idea of the 

[Goanet] Phoenician ? (thank you Frederic Noronha )

[eric pinto]

  The science now prefers the 'Coptic' label. The Maltese consider themselves 
Semiticas do Finland and neighbour Karalia which Stalin annexed.
Some ancient colonies:

* Carthage formed as a Phoenician colony
* Cadiz formed as a Phoenician colony
* Cyrene was a colony of the Greeks of Thera
* Sicily was a Phoenician colony
* Durrës formed as a Greek colony
* Sardinia was a Phoenician colony
* Marseille formed as a Greek colony
* Malta was a Phoenician colony
* Cologne formed as a Roman colony, its modern name refers to Latin "Colonia".
* Kandahar formed as a Greek colony by Alexander the Great in 330 BC
 
   • Privacy • Unsubscribe • Terms of Use 
 .  
 __,_._,___  

[Goanet] INDIA NEEDS THE ‘GARIBI HATAO’ SLOGAN BACK-CSE’s Bulletin October 12, 2020

[Vikas Khanna]

Can't see images? View in browser


CSE’s Weekly News Bulletin

October 12, 2020

Sign up for newsletter


BULLETIN HIGHLIGHTS

Stories from Down To Earth

Online Events

New Publications

 

India needs the ‘Garibi Hatao’ slogan back 

Officially, one can argue: India doesn’t have poverty. This is
because we don’t know who is poor in the country. And this is due to
another case of governance mala fide. We have not counted the poor in
the country for nearly a decade now. The last one, released in 2019,
was junked by the Union government; probably it showed a poverty level
politically not suitable for the ‘New India’ slogan.

But why do we need to talk about poverty, or garibi, now? First, we
have stopped taking stock of poverty as mentioned above. This makes it
difficult to assess the impacts of hundreds of development programmes
India implements, ironically to eradicate poverty not even knowing
about it.

However, our development schemes continue to target a section of
people referred to as below the poverty line (BPL), identified years
ago. Second, going by all economic indicators of recent years, it is
certain that a large section of the country remains poor or is not
able to reach a decent level of living.

Third, if despite investing so much political and monetary capital,
the development indicator is not positive, then we need to reassess
our anti-poverty programmes. This is also because there is a section
of the population in a certain geography who remain poor despite
decades of focused intervention... Continue Reading


Announcements – Online Events

 

Online Training

Basics of GIS and Remote Sensing for Water and Sanitation, Oct 26-Nov
06, 2020


 

Online training

Safe Water, Sanitation and Health for all during and post COVID19, Oct
28- Nov 30, 2020


 

Online Global Training Programme

Faecal sludge management in rural areas, Oct 30- Nov 12, 2020


 

Online Training

Understanding Environmental Laws for Better Environmental Management,
Nov 1-10, 2020


 

Online Training

Making Data Meaningful, Nov 2-7, 2020


 

Online Training

Sustainable E-Waste Management, Nov 5-10, 2020